Area of Specialization
Interventional Cardiology
Office Locations
Olean General Hospital
515 Main Street
Olean, NY 14760
Phone: (716) 375-7035
Fax: (716) 375-7037
Education
- Fellowship, Interventional Cardiology, University of Pennsylvania Health System, Philadelphia
- Fellowship, Electrophysiology, University of Pennsylvania Health System, Philadelphia
- Fellowship, Clinical Cardiology, University of Pennsylvania Health System, Philadelphia
- Residency, Internal Medicine, State University of New York at Stony Brook
- Doctor of Medicine, State University of New York Downstate College of Medicine, Brooklyn, NY
- Bachelor of Science, Chemistry, Creighton University, Omaha, Nebraska
Accreditations/Associations
- Fellow, American College of Cardiology
- Fellow, Society of Cardiovascular Angiography and Intervention
Publications/Presentations
- The PRICE Investigators. Comparative 30-Day Economic and Clinical Outcomes of Platelet Glycoprotein IIb/IIa Inhibitor Use During Elective Percutaneous Coronary Intervention: Prairie ReoPro versus Integrilin Cost Evaluation (PRICE) Trial. Am Heart J 141:402-9, 2001.
- Inhibition on Clinical Outcomes. Poster abstract XXII EOS Annual Congress: 8/26-30, 2000, Amsterdam, The Netherlands.Aguirre FV, Mishkel GJ; Rosha-Singh KJ; Gill JB; Kacich RL; Moses HW; Mikel FL; Mayer SA; Mallavarapu CT; Lucore CL; Lam W; Shelton ME; Steen MS; Trask RV; Yakel D. In-Hospital and 30-Day Economic and Clinical Outcomes with Platelet GP IIb/IIIa ReoPro vs Integrilin Therapy During Percutaneous Coronary Intervention. (PRICE Trial). Abstract, AHA, 11/12-15/2000, New Orleans, LA.
- Aguirre FV, Mishkel GJ; Rosha-Singh KJ; Gill JB; Kacich RL; Moses HW; Mikel FL; Mayer SA; Mallavarapu CT; Lucore CL; Lam W; Shelton ME; Steen MS; Trask RV; Yakel D. Comparison of Platelet Inhibition Achieved with Abciximab vs Eptifibatide During Percutaneous Coronary Intervention: Influence of Platelet Inhibition on Clinical Outcomes. Poster Abstract, AHA, 11/12-15, 2000, New Orleans, LA.
- Frank V; Aguirre FV; Gregory J; Mishkel GJ; Singh IV; Mayer A; Gill J; Shelton M; Yakel D; Lam W; Mallavarapu C; Antezano E; Kodali D; Holloway C. Overestimation of Tirofiban-Mediated Platelet Inhibition During Percutaneous Coronary Intervention: Impact of Sodium Citrate Poster Abstract, AHA, 11/12-15, 2000, New Orleans, LA.